Claude Paoletti

Claude Paoletti's AcademicInfluence.com Rankings

Claude Paoletti

Chemistry

#3057

World Rank

#4043

Historical Rank

Physical Chemistry

#390

World Rank

#439

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Claude Paoletti's Degrees

PhD Chemistry Université Paris Cité
Bachelors Chemistry Université Paris Cité

Why Is Claude Paoletti Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Claude Paoletti's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization. (1967) (2112)
A new fluorometric method for RNA and DNA determination. (1966) (624)
Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. (1991) (564)
Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. (1988) (421)
Progress in Molecular and Subcellular Biology 3 (1973) (309)
[Electrochemotherapy, a new antitumor treatment: first clinical trial]. (1991) (292)
Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. (1988) (286)
A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs. (1974) (176)
Electrochemotherapy of spontaneous mammary tumours in mice. (1991) (165)
cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA (1990) (161)
Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137). (1980) (110)
α-DNA II. Synthesis of unnatural α-anomeric oligodeoxyribonucleotides containing the four usual bases and study of their substrate activities for nucleases (1987) (100)
Control of UV induction of recA protein. (1983) (87)
α-DNA VI: comparative study of α- and β-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition (1987) (84)
Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264--137) in advanced human cancers. (1978) (82)
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system. (1981) (81)
Relative efficiencies of a series of square-planar plantinum(II) compounds on Salmonella mutagenesis. (1977) (80)
Characterization of a new class of circular DNA molecules in yeast. (1971) (79)
Ellipticines as potent inhibitors of aryl hydrocarbon hydroxylase: their binding to microsomal cytochromes P450 and protective effect against benzo(a)pyrene mutagenicity. (1978) (79)
Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L 1210 leukemia. (1979) (70)
Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship. (1992) (67)
The use of ethidium bromide-circular DNA complexes for the fluorometric analysis of breakage and joining of DNA. (1971) (63)
Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative. (1991) (60)
Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives. (1984) (59)
Preparation and properties of nuclear and satellite deoxyribonucleic acid of Trypanosoma cruzi. (1967) (59)
An analytical study of the dimerization of in vitro generated RNA of Moloney murine leukemia virus MoMuLV. (1990) (55)
A yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide. (1972) (52)
Purification and characterization of recA protein from salmonella typhimurium. (1983) (41)
Initial degradation of deoxyribonucleic acid after injection in mammals. (1965) (38)
Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitro. (1986) (38)
Binding of ellipticine base and ellipticinium cation to calf-thymus DNA. A thermodynamic and kinetic study. (1988) (38)
Comparative activity of α- and β-anomeric oligonucleotides on rabbit β globin synthesis: Inhibitory effect of cap targeted α-oligonucleotides (1989) (38)
Antitumor activity of 9-hydroxyellipticine (NSC 210717) ON L1210 mouse leukemia and the effect of route of injection. (1976) (38)
The hydroxylation of the antitumor agent, ellipticine, by liver microsomes from differently pretreated rats. (1977) (36)
Ellipticines as potent inhibitors of microsomes-dependent chemical mutagenesis. (1979) (36)
Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro. (1979) (35)
A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine). Synthesis, DNA binding, and biological properties. (1988) (34)
Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella. (1983) (34)
Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl. (1987) (32)
Synthesis, DNA binding, and biological evaluation of synthetic precursors and novel analogues of netropsin. (1989) (32)
α-DNA VIII: thermodynamic parameters of complexes formed between the oligo-alpha-deoxynucleotides: α-d(GGAAGG) and α-d(CCTTCC) and their complementary oligo-beta-deoxynucleotides: β-d(CCTTCC) and β-d(GGAAGG) are different (1989) (32)
omicron-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate. (1983) (31)
Autoxidation of the antitumor drug 9-hydroxyellipticine and its derivatives. (1983) (29)
Lipid peroxidation in liver: hydroxy dimethyl carbazole a new potent inhibitor. (1980) (29)
Structure-activity relationships in the inhibitory effects of ellipticines on benzo(a)pyrene hydroxylase activity and 3-methylcholanthrene mutagenicity. (1980) (28)
Yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide. 1. Purification and properties. (1979) (28)
A carboline derivative as a novel mammalian DNA topoisomerase II targeting agent. (1992) (27)
Unexpected regiospecific alkylation of the antitumor agent N2-methyl-9-hydroxyellipticinium acetate with N, O or S donors (1983) (27)
The G.C base-pair preference of 2-N-methyl 9-hydroxyellipticinium. (1989) (26)
α-DNA IV: α-anomeric and β-anomeric tetrathymidylates covalently linked to intercalating oxazolopyridocarbazole. Synthesis, physicochemical properties and poly (rA) binding (1987) (25)
The hepatic metabolism of ethidium bromide to reactive mutagenic species: biochemical and structural requirements. (1981) (25)
Bis(pyrrolecarboxamide) linked to intercalating chromophore oxazolopyridocarbazole (OPC): selective binding to DNA and polynucleotides. (1991) (24)
α-Anomeric DNA: β-RNA hybrids as new synthetic inhibitors of Escherichia coli RNase H, Drosophila embryo RNase H and M-MLV reverse transcriptase (1988) (24)
A revised structure of the antitumor drug elliptinium--amino(acid) adducts. (1985) (24)
Identification of the glucuronide and glutathione conjugates of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate (Celiptium). Comparative disposition of this drug with its olivacinium isomer in rat bile. (1984) (24)
Synthesis, thermal stability and reactivity towards 9-aminoellipticine of double-stranded oligonucleotides containing a true abasic site. (1989) (23)
A protein inhibitor of acid deoxyribonucleases. (1969) (23)
An immunoradiometric quantitative assay of Escherichia coli recA protein. (1982) (22)
Voltage-dependent introduction of a d[α]octothymidylate into electropermeabilized cells (1989) (22)
Metabolism of ellipticine and derivatives and its involvement in the antitumor action of these drugs (1978) (21)
Some antitumor derivatives of ellipticine deprived of mutagenic properties. (1978) (21)
Yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide. 2. Mechanism of enzyme activation. (1979) (21)
Human and rat urinary metabolites of the antitumor drug Celiptium (N2-methyl-9-hydroxyellipticinium acetate, NSC 264137). Identification of cysteine conjugates supporting the "biooxidative alkylation" hypothesis. (1983) (21)
Synthesis and cytotoxic activity of hydroxylated derivatives of olivacine in relation with their biotransformation. (1985) (20)
Peroxidase-catalysed covalent binding of the antitumor drug 2N-methyl-9-hydroxy-ellipticine to proteins. (1983) (20)
Different levels of induction of RecA protein in E. coli (PQ 10) after treatment with two related carcinogens. (1983) (20)
Interactions between ellipticine and some derivatives and phospholipids in model membranes (1979) (19)
Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione. (1991) (18)
Infectious and Oncogenic Effect of DNA Extracted from Cells Infected with Polyoma Virus (1964) (18)
Mechanism of cleavage of apurinic sites by 9-aminoellipticine. (1989) (18)
Efficient breakage of DNA apurinic sites by the indoleamine related 9-amino-ellipticine. (1986) (18)
Metabolism of the anti-tumour drugs N2-methyl-9-hydroxyellipticinium acetate (NSC 264137) and N2-methyl-9-hydroxyolivacinium acetate in the rat: preliminary identification of biliary 9-(O)-glucuronide and 10-(S)-glutathione conjugates. (1983) (18)
[Potentiation of the antitumoral effect of electrochemotherapy by immunotherapy with allogeneic cells producing interleukin 2]. (1992) (17)
Ellipticines as potent inhibitors of drug metabolism. Protective effect against chemical mutagenesis and carcinogenesis (1978) (16)
Circular oligomers in mitochondrial DNA of human and beef nonmalignant thyroid glands. (1972) (16)
Anti-sense oligonucleotides as potential antitumour agents: prospective views and preliminary results. (1988) (16)
Covalent binding of the antitumor agent N2-methyl-9-hydroxy-ellipticinium acetate (NSC 264137) on RNA and poly A in vitro. (1984) (15)
Toxicological and pharmacological studies on 9-hydroxy-ellipticine in mice. (1975) (15)
Urinary β-Amino Isobutyric Acid in the Mouse: Elimination after Intravenous Administration of Deoxyribonucleic Acid (1965) (14)
Electrophoretic Pattern of Plasma Proteins in Rats treated with Trypan Blue and Ethionine (1962) (14)
Mitochondrial and nuclear mutagenicity of ellipticine and derivatives in the yeast Saccharomyces cerevisiae. (1982) (14)
Does cruciform DNA provide a recognition signal for DNA-topoisomerase II? (1992) (14)
Stimulation by γ-carboline derivatives (simplified analogues of antitumor ellipticines) of site specific DNA cleavage by calf DNA topoisomerase II (1990) (13)
Heterocyclic Quinones. 4. A new highly cytotoxic drug: 6,7-bis(1-aziridinyl)-5,8-quinazolinedione. (1983) (13)
Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells. (1986) (13)
Metabolism and disposition studies of 9-hydroxyellipticine and 2-methyl-9-hydroxyellipticinium acetate in animals. (1980) (12)
Inhibition of moloney murine leukemia virus reverse transcriptase by α-anomeric oligonucleotides (1989) (11)
Regioselective arylation of ribose in adenosine and guanosine with the antitumor drug N2-methyl-9-hydroxyellipticinium acetate. (1984) (11)
Mechanism of deoxyribonucleic acid degradation by an acid deoxyribonuclease from the snail Helix aspersa Müll. (1972) (11)
Ethidium bromide mutagenesis in yeast: protection by anaerobiosis. (1975) (11)
The localization of topoisomerase II cleavage sites on DNA in the presence of antitumor drugs. (1993) (10)
Purification and properties of an acid deoxyribonuclease from the snail Helix aspersa Müll. (1972) (10)
Pattern of recognition of DNA by mammalian DNA topoisomerase II. (1988) (10)
Frameshift mutagenesis in Escherichia coli by reversible DNA intercalators: sequence specificity. (1988) (9)
Frameshift mutagenesis in Salmonella typhimurium by reversible DNA intercalators: effect of a UVR B mutation. (1986) (9)
Influence of inducers of monooxygenases on cytotoxic efficiency of ellipticine on leukemia L1210 cells. (1981) (9)
A spectrofluorometric method for the study of transcription of single-stranded DNA by RNA polymerase. (1966) (9)
Selective binding of elliptinium acetate onto the 3'-terminal ribose of diribonucleosides monophosphates. (1985) (9)
Structural changes of polyriboinosinic acid induced by a steroidal diamine, irehdiamine A. (1967) (9)
α -DNA X: α and β tetrathymidilates covalently linked to oxazolopyridocarbazolium (OPC): comparative stabilization of oiigo β -[dT]:oligo β -[dA] and oligo α -[dT]:oligo β -[dA] duplexes by the intercalating agent (1989) (9)
HETEROCYCLIC QUINONES. VI: SYNTHESIS AND ANTITUMORAL EFFECTS OF 5,10-BENZO(G)QUINOXALINEDIONES AND AZA-ANALOGS (1985) (9)
Stacking and edge‐to‐edge associations of antitumoral ellipticine derivatives are controlled in solution by interactions involving their nitrogen sites (1988) (9)
Cardiovascular activity of 9-hydroxy-ellipticine. (1976) (8)
[Mitochondrial DNA of malignant cells]. (1970) (8)
Heterocyclic quinones. XIII. Dimerization in the series of 5,8-quinazolinediones: synthesis and antitumor effects of bis(4-amino-5,8-quinazolinediones). (1988) (8)
Studies on the specificity of an acid deoxyribonuclease from Helix aspersa (Müll.). (1973) (8)
Use of a new DNA intercalating fluorescing probe for studies on the mechanism of frameshift mutagenesis in Salmonella typhimurium. (1985) (8)
α-Oligodeoxynucleotide Analogues (1989) (8)
Ellipticine, 9-hydroxyellipticine, and 9-hydroxyellipiticinum: some biochemical properties of possible pharmacologic significance. (1981) (7)
Synthesis of 11-amino-substituted-9-methoxy-5-methyl-6H-pyrido[4,3-b]-carbazoles (1991) (7)
Synthesis, DNA binding and biological activity of oxazolopyridocarbazole-netropsin hybrid molecules (1991) (7)
Measurement of recA protein induction in Salmonella typhimurium: a possible biochemical test for the detection of DNA damaging agents. (1982) (7)
BIOACTIVATION OF THE ANTITUMOR DRUGS 9-HYDROXYELLIPTICINE AND DERIVATIVES BY A PEROXIDASE-HYDROGEN PEROXIDE SYSTEM (1981) (7)
O-QUINONE FORMATION IN THE BIOCHEMICAL OXIDATION OF THE ANTITUMOR DRUG N2-METHYL-9-HYDROXYELLIPTICINIUM ACETATE (1983) (7)
Relationship between cytostatic activity of oxazolopyridocarbazoles and accessibility of DNA intercalation sites in living bacteria. (1986) (6)
Effects of 9‐hydroxyellipticine on growth and macromolecular synthesis in Escherichia coli (1976) (6)
Heterocyclic quinones VIII. Synthesis and anti-neoplastic evaluation of 7-substituted-1H-pyrrolo[3,2-c]quinoline-6,9-diones and 3-substituted-11H-indolo[3,2-c]quinoline-1,4-diones (1987) (6)
alpha-DNA. VI: Comparative study of alpha- and beta-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition. (1987) (5)
Interest of Quantum Mechanical Calculations for the Design of Anticancerous Drugs in the Series of Ellipticines (1974) (5)
Quantification by fluorescence of apurinic sites in DNA. (1987) (5)
Frameshift lesions induced by oxazolopyridocarbazoles are recognized by the mismatch repair system in Escherichia coli. (1988) (5)
Antitumor Activity, Pharmacology and Clinical Trials of Elliptinium (NSC 264-137) (1986) (4)
Synthesis of (O)-glucosides of N2-methyl-9-hydroxyellipticinium and related biological studies (1984) (4)
alpha-DNA II. Synthesis of unnatural alpha-anomeric oligodeoxyribonucleotides containing the four usual bases and study of their substrate activities for nucleases. (1987) (4)
[17] Fluorometric assay for specific (nickases) and nonspecific endodeoxyribonucleases (1971) (4)
[Hydroxy 9-methyl 2-ellipticinium acetate (NSC 264-137). Toxicologic study and therapeutic effect in 100 cancers (author's transl)]. (1979) (4)
Metabolism of ethidium bromide in rats. (1981) (3)
25 Inhibition of the in vitro growth rate of L1210 leukemic cells by platinum(II) derivatives (1978) (3)
Synergic effect of NADP+ on the antitumor properties of low doses of 9 OH-ellipticine towards Walker cells. (1983) (3)
Rearrangement of mitochondrial DNA molecules during the differentiation of mitochondria in yeast. II. - Labelling studies of the precursor product relationship. (1975) (3)
[Plasmatic iron & synthesis of hemoglobin]. (1958) (3)
Localization and Fractional Determination of Neutral Deoxyribonuclease Activity in Cat Serum (1963) (3)
New anti cancer derivatives in the ellipticine series (1978) (3)
[Induction of rat hepatic mono-oxygenases by ellipticine: formation of cytochrome p448. Hydroxylating activity]. (1976) (3)
Oxidative biotransformation of the antitumour agent elliptinium acetate: Structural characterization of its human and rat urinary metabolites. (1987) (3)
Apurinic DNA: Modelisation and Reactivity Towards 9-Aminoellipticine and Related Amines (1989) (3)
Metabolic transformation of 2-methylellipticinium. (1980) (3)
Bis-Pyrrolecarboxamides Linked to Intercalating Chromophore Oxazolopyridocarbazole (OPC): Properties Related to the Selective Binding to DNA at Rich Sequences (1990) (2)
A new extraction procedure of autonomous DNA from eucaryotic cells, where DNA could be bound to proteins. (1990) (2)
Comparative activity of alpha- and beta-anomeric oligonucleotides on rabbit beta globin synthesis: inhibitory effect of cap targeted alpha-oligonucleotides. (1989) (2)
Chemical structure of ethidium bromide metabolites extracted from rat bile (1981) (2)
[Interaction of ethidium hydrobromate (EH) with polyribonucleotides. Applications to the study of hybridization reactions]. (1965) (2)
Lack of single-strand DNA-binding protein amplification under conditions of SOS induction in E. coli (2004) (2)
[Absence of consummation of siderophilin during hemoglobin synthesis in vitro]. (1958) (2)
55 Peroxidases-catalyzed oxidation of the antitumor drug 9-hydroxy-ellipticine (1978) (2)
[Physiopathologic studies on myeloid splenomegaly with myelofibrosis; studies with radioactive iron and chromium]. (1957) (2)
Stimulation by gamma-carboline derivatives (simplified analogues of antitumor ellipticines) of site specific DNA cleavage by calf DNA topoisomerase II. (1990) (2)
[In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship]. (1994) (2)
In Vitro Oxidative Activation: A Model for the Cytotoxic Action of 9-Hydroxy Ellipticine Derivatives (1983) (2)
[Ineffectiveness of hydrogen peroxide in grafted animal tumors]. (1959) (1)
[A new antitumor compound: hydroxy-9 ellipticin. Effect on mouse L 1210 leukemia]. (1973) (1)
[Demonstration of the O-demethylation reaction catalyzed by a peroxidase: application to 9-methoxyellipticine]. (1984) (1)
[EFFECT OF LEUKOCYTE RESTORATION BY DESOXYRIBONUCLEIC ACID INJECTED INTO SWISS MICE AFTER IRRADIATION WITH 700 RADS. INFLUENCE OF PREVIOUS INGESTION OF 2-AMINOETHYLISOTHIOURONIUM (AET) AND THIOGEL]. (1964) (1)
Alpha-anomeric DNA: beta-RNA hybrids as new synthetic inhibitors of Escherichia coli RNase H, Drosophila embryo RNase H and M-MLV reverse transcriptase. (1988) (1)
Alpha-DNA. IV: Alpha-anomeric and beta-anomeric tetrathymidylates covalently linked to intercalating oxazolopyridocarbazole. Synthesis, physicochemical properties and poly (rA) binding. (1987) (1)
[INTERACTION OF ETHIDIUM BROMHYDRATE (BET) WITH NUCLEIC ACIDS (NA). SPECTROFLUORIMETRIC STUDY]. (1964) (1)
AUTOXIDATION OF THE ANTITUMOR DRUG 9-HYDROXYELLIPTICINE AND ITS DERIVATIVES (1984) (1)
Isolation and characterization of the glutathione-elliptinium conjugate in human urine. (1987) (1)
Synthesis, DNA binding properties and biological evaluation of novel oligo-meta-benzamides related to netropsin (1991) (1)
[Production of tumors in the hamster by inoculation of desoxyribonucleic acid extracted from tissue cultures infected with polyoma virus]. (1962) (1)
Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites (2004) (1)
alpha-DNA X: alpha and beta tetrathymidilates covalently linked to oxazolopyridocarbazolium (OPC): comparative stabilization of oligo beta-[dT]:oligo beta-[dA] and oligo alpha-[dT]:oligo beta-[dA] duplexes by the intercalating agent. (1989) (1)
[In vitro study of hemin synthesis in bone marrow erythroblasts]. (1957) (1)
[Depressive action of cortisone on hemoglobin synthesis in vitro]. (1957) (1)
[DESOXYRIBONUCLEIC ACID CATABOLISM AFTER INTRAVENOUS INJECTION IN RABBITS. THE INFLUENCE OF PLASMA DESOXYRIBONUCLEASE]. (1963) (1)
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)]. (1981) (1)
[DEMONSTRATION AND PROPERTIES OF 1 (OR SEVERAL) NATURAL INHIBITOR(S) OF PANCREATIC NEUTRAL DESOXYRIBONUCLEASE]. (1963) (1)
In vitro Examination of the Ribonucleic Acid–Deoxyribonucleic Acid–Deoxyribonuclease System in Mammals (1962) (1)
Voltage-dependent introduction of a d[alpha]octothymidylate into electropermeabilized cells. (1989) (1)
Regioselective 2′-O Sugar Arylation in Adenine Nucleosides by The Elliptinium Agetate, An Antitumor Agent (1985) (1)
[Studies on the toxicity of 9-hydroxyellipticine]. (1974) (1)
[Study of displacement reactions between polyribonucleotides by use of ethidium hydrobromate (ETB). Demonstration of displacement of the poly (A-2 I) by poly U]. (1965) (1)
Contents, Vol. 14, 1976 (1976) (0)
[Cardiovascular effect and toxicity of hydroxy-9-ellipticine in dogs]. (1974) (0)
[Comparative splenic lesions secondary to selective local irradiation of the spleen to total body irradiation with x-rays in rats]. (1955) (0)
[The penetration of iron in red cells in vitro]. (1955) (0)
[Role of plasma beta-globulines in transport of iron used by erythropoietic cells]. (1957) (0)
[Isolation and fractionation of yeast deoxyribonucleic acid (DNA)]. (1966) (0)
Chronique de LivresCancer biochemistry biophysics, no 1. — (Gordon and Breach Science, Publ., 42 William IX Street, London W.C.2). (1975) (0)
[The quantitative determination of non-hemoglobinic iron of erythrocytes, its value in the course of certain erythropathies]. (1958) (0)
POTENTIAL ANTITUMOR AGENTS: SYNTHESIS AND BIOLOGICAL PROPERTIES OF ALIPHATIC AMINO ACID 9-HYDROXYELLIPTICINIUM DERIVATIVES (1985) (0)
Synthesis of 11‐Amino‐substituted‐9‐methoxy‐5‐methyl‐6H‐pyrido(4,3‐b) carbazoles (XII). (1992) (0)
54 Ellipticines: antitumor properties and metabolism (1978) (0)
Heterocyclic Quinones. Part 17. A New in vivo Active Antineoplastic Drug: 6,7‐Bis(1‐aziridinyl)‐4‐((3‐(N,N‐dimethylamino)propyl)amino)‐5,8‐ quinazolinedione. (1991) (0)
[Absorption and distribution of barium administered by intravenous or oral route in the rat]. (1957) (0)
Experimental Studies on the Toxicology of Benzene. Modifications of Erythropoiesis followed by the Use of Radioactive Iron. (1959) (0)
[The structure of hemoglobins and its functional implications]. (1967) (0)
Comparison (nature and biological activity) between two new blue species involving, respectively, malonamide and succinamic acid as ligands (1983) (0)
[Generalities on the use of isotopes in experimental toxicology; application to the study of the toxicity of products used in anticancerous chemotherapy]. (1957) (0)
[Various concepts on the biology and therapy of radiation injuries]. (1956) (0)
[Sources & detection of radioactive substances in toxicology]. (1957) (0)
Alpha-DNA VIII: thermodynamic parameters of complexes formed between the oligo-alpha-deoxynucleotides: alpha-d(GGAAGG) and alpha-d(CCTTCC) and their complementary oligo-beta-deoxynucleotides: beta-d(CCTTCC) and beta-d(GGAAGG) are different. (1989) (0)
Comparison of anti-RNA properties of normal and ellipticine functionalized alpha and beta-oligonucleotides. (1991) (0)
[Splenic lesions induced by selective irradiation of the spleen, partial or total irradiation of the organism]. (1956) (0)
[Frequency of thymic lymphosarcomas in the descendants of RF mice irradiated before mating]. (1960) (0)
Cancer Cells: 3/1985. Growth Factor and Transformation. J. Feramisco and Coll. Cold Spring Harbor Laboratory, Basel (1985) (1986) (0)
EFFET DE LA CONCENTRATION EN SUBSTRAT SUR LA CIN'ETIQUE D'ACTION DE LA D'ESOXYRIBONUCL'EASE NEUTRE PANCR'EATIQUE. (1964) (0)
alpha Oligonucleotide probes (1987) (0)
179 – ELLIPTICINES AS POTENT INHIBITORS OF BENZO (a) PYRENE HYDROXYLASE. PROTECTIVE EFFECTS AGAINST CHEMICAL MUTAGENESIS AND CARCINOGENESIS (1978) (0)
[Evolution of the radioactivity of desoxyriboucleic acid in the mouse following the administration of tritiated thymidine]. (1962) (0)
Derivatives of 4-amino-5,8 quinazolinedione, their process for the preparation and pharmaceutical compositions containing them (1987) (0)
[Fractionation by starch gel electrophoresis of the plasma proteins of different animal species]. (1962) (0)
[INHIBITION OF SPLENIC ACID DESOXYRIBONUCLEASE (DNASE II) BY RIBONUCLEIC ACIDS (RNA)]. (1964) (0)
[Fractionation and characterization of desoxyribonucleic acid (DNA) of trypanosomes (Trypanosoma equiperdum)]. (1966) (0)
[Toxicological study of 2-aminoethylisothiouronium hydrobromide (AET). Use of AET as a protector against radio-mimetic agents]. (1962) (0)
Heterocyclic Quinones. Part 13. Dimerization in the Series of 5,8-Quinazolinediones: Synthesis and Antitumor Effects of Bis(4-amino-5,8-quinazolinediones). (1989) (0)
SYNTHESIS AND CYTOTOXIC ACTIVITY OF HYDROXYLATED DERIVATIVES OF OLIVACINE IN RELATION WITH THEIR BIOTRANSFORMATION (1985) (0)
[Study on the extraction and in vitro infective power of polyoma virus desoxyribonucleic acid]. (1963) (0)
[Protective role of cortisone against the aplastic effects of methyl bis (beta-chlorethyl) amine on the bone marrow of the rat]. (1956) (0)
[Tests of new derivatives of colchicine on experimental grafted tumors]. (1959) (0)
RADIOACTIVE WASTES RESULTING FROM THE PEACEFUL OR MILITARY UTILIZATION OF ATOMIC ENERGY (1957) (0)
[Purification and properties of a snail (Helix pomatia L.) hepato-pancreas acid desoxyribonuclease]. (1966) (0)
HETEROCYCLIC QUINONES. I. 1,4-ACRIDINEDIONES: POTENTIAL ANTITUMORAL AGENTS (1981) (0)
Control of UV induction of recA protein (Escherichia coli/UV irradiation/SOS functions/recF/immunoradiometric assay) (2016) (0)
[Kinetic study of the replicative forms of DNA in animal cells]. (1967) (0)
SYNTHESIS, DNA INTERCALATION AND ANTITUMOR ACTIVITY OF 9-HYDROXY-11-DEMETHYLELLIPTICINE AND SOME DERIVATIVES. COMPARISON WITH THE CORRESPONDING ELLIPTICINES (1981) (0)
Subject Index Vol. 14, 1976 (1976) (0)
THE PHYSIOPATHOLOGIC EFFECTS OF RADIATIONS DUE TO NUCLEAR EXPLOSIVES (1962) (0)
[Experimental research on cytosiderosis caused by wine]. (1961) (0)
ABSORPTION AND DISTRIBUTION OF BARIUM ADMINISTERED INTRAVENOUSLY AND ORALLY IN THE RAT (1957) (0)
[Studies on the interaction of a diamine steroid, irehdiamine A, with desoxyribonucleic acid]. (1968) (0)
STUDIES ON DNA REPLICATION IN ANIMAL CELLS. Annual Report. (1966) (0)
[Not Available]. (1956) (0)
[Ethidium bromhydrate effect on L 1210 mouse leukemia]. (1974) (0)
[Inhibition of hemoglobin synthesis in vitro by beta-chloroethyl compounds]. (1956) (0)
[Measurement of erythrocyte formation in man using radioactive chromium]. (1958) (0)
[Protective action of beta-mercaptoethylamine against methylbis(beta-chlorethyl)amine in rats]. (1956) (0)
[2 new antineoplastic derivatives: 9-hydroxy-2-methyl-ellipticinium (acetate) and 9-hydroxy-2,6-dimethyl-ellipticinium (chloride). Effect on mouse L 1210 leukemia]. (1975) (0)
Role of single-stranded binding protein (SSB) in the induction of the SOS repair system (1984) (0)
[Effect of the selective irradiation of the spleen on Fe59 metabolism in rats]. (1956) (0)
[Research on the toxicity of a new substance proposed as anticancer agent: 2, 5-di-ethyleneimino-3, 6-dipropoxyquinone]. (1957) (0)
Letter from Claude Paoletti to Joshua Lederberg (1968) (0)
[Infectious desoxyribonucleic acid extracted from cultures of kidney cells of the baboon infected by SV 40 virus]. (1962) (0)
Unexpected Regiospecific Alkylation of the Antitumor Agent N2-Methyl-9-hydroxyellipticinium Acetate with N, O or S Donors. (1983) (0)
HETEROCYCLIC QUINONES. 4. A NEW HIGHLY CYTOTOXIC DRUG: 6,7-BIS(1-AZIRIDINYL)-5,8-QUINAZOLINEDIONE (1984) (0)
[Splenic lesions induced in the rat by segmental or global irradiation of the organism, or by selective irradiation of the spleen]. (1958) (0)
[Use of radioactive chromium for the purpose of a quantitative evaluation of erythropoiesis]. (1957) (0)
Method of preparation of derivatives of ellipticine, new compounds thus obtained and their anti-tumor activity (1982) (0)
[Presence of specific inclusions in newborn mouse kidney cell cultures inoculated with polyoma virus or its nucleic acid]. (1962) (0)
[Modifications in erythropoietic cellular metabolism under the influence of sulfide of bis-(beta-chlorethyl), yperite]. (1956) (0)
Regioselective arylation of ribose in adenosine and guanosine with the antitumor drug NV-methyl-9-hydroxyellipticinium acetate ( nucleoside / horseradish peroxidase / ellipticine ) (0)
[EFFECT OF SUBSTRATE CONCENTRATION ON THE ACTION KINETICS OF PANCREATIC NEUTRAL DESOXYRIBONUCLEASE]. (1964) (0)
[Experimental studies on the toxicology of benzene; changes of erythropoiesis followed by radioactive iron]. (1959) (0)
[Existence of duplicative forms of DNA in animal cells]. (1965) (0)
HETEROCYCLIC QUINONES. II. QUINOXALINE-5,6-(AND 5-8)-DIONES OF POTENTIAL ANTITUMOR ACTIVITY (1982) (0)
a-DNA X: a and j3 tetrathynidilates covalently linked to oxazolopyridocarbazolium (OPC): comparative stabilization of oligo (3-[dT]:oligo fl-[dA] and oligo a-[dT]:oligo ,3-[dA] duplexes by the intercalating agent (0)
[On the determination of iron and on latent capacity for the fixation of this metal in the blood serum by terpyridine. Its application for the determination of iron in the blood and in various organs]. (1959) (0)
[Atomic traumatism]. (1954) (0)
[Anemia in acute leukosis]. (1955) (0)
[Protective effect of sodium hyposulfite against tri(beta-chloroethyl) amine (HN3) in rats]. (1957) (0)
[Study of the interaction between a diaminosteroid, Irehdiamine A and transfer RNA]. (1969) (0)
Derivatives of 9-hydroxy ellipticine and therapeutic purposes (1975) (0)
Inhibition of Moloney murine leukemia virus reverse transcriptase by alpha-anomeric oligonucleotides. (1989) (0)
[Metabolic heterogenicity of hemoglobin of the blood of the cold investigated with the air of radioactive iron and glycocoll]. (1955) (0)
[Inhibition of hemoglobin metabolism in reticulocytes by beta-chloroethyl compounds]. (1956) (0)
[CHROMATOGRAPHY ON METHYLATED ALBUMIN OF RADIOACTIVE DNA EXTRACTED FROM ASCITES CELLS]. (1964) (0)
HETEROCYCLIC QUINONES. III. BENZO(F)QUINOLINE-7,10-DIONES, AS POTENTIAL ANTITUMOR AGENTS (1983) (0)
[Attempted application of electrophoresis on starch gel in clinical biology]. (1960) (0)
[Extraction of desoxyribonucleic acid from different tissues using papain]. (1963) (0)
[The distribution of radioiron in the rabbit after experimental poisoning by benzene]. (1958) (0)

This paper list is powered by the following services:

Claude Paoletti's Academic­Influence.com Rankings

Claude Paoletti's Degrees

Why Is Claude Paoletti Influential?

Claude Paoletti's Published Works

Published Works

Claude Paoletti's AcademicInfluence.com Rankings